The results of the present study warrant detailed analysis using animal models and clinical samples to decipher the molecular mechanisms underlying Rb pathogenesis, elucidate the role of UNC5D in Rb tumors and identify if E2F3, ESR1 and UNC5D could act as novel and promising targets for early diagnosis and treatment of Rb. This evidence concerns the gene E2F3 and retinoblastoma.